Advance key molecular characterizations for the emergence of more targeted and precise treatments in oncology
Hear from and meet with the leading figures in precision oncology to explore how companies are innovating in precision medicine, digital pathology and molecular testing to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation
This event is co-located with Targets & Cell Types in Immuno-Oncology Europe 2023 & Biomarkers Europe 2023
The event provides an additional 15+ presentations on precision oncology research at the basic, translational
and clinical application levels, with exploration of the latest reverse translation and digital pathology technologies
to better understand the tumour microenvironment, alongside emerging therapeutic opportunities in immuno-oncology.
The 2022 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below are some of our confirmed speakers for Precision Oncology Europe 2023
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.